SUBRAMANIAN SANJAY (SVP, CFO) received a stock award from INOZYME PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/27/2025ACC: 0000950170-25-090862
Officer· SVP, CFO
Since Mar 2022
+6.81K
Net shares
Net buyer
$5.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
6.81K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.81K
Price / share
$0.74
Trade value
$5.04K
% of position
20.7%
6/25/2025
32.89K→39.70K
Total
Net shares
+6.81K
Net value
$5.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/25/2025 | A · Award | +6.81K | $0.74 | $5.04K | 20.7% | 32.89K | 39.70K |
| Total | +6.81K | $5.04K | ||||||
Derivative Transactions0
No derivative transactions reported